Defibrillators Market Analysis By Product (Implantable Cardioverter Defibrillator, External Defibrillator), By End-use (Hospital, Pre-hospital, Public Access Market, Alternate Care Market, Homes) And Segment Forecasts To 2020

Published: Mar, 2015 | Pages: 83 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)

Global defibrillator market is expected to reach USD 15.75 billion by 2020. Defibrillators, owing to their capability to resolve cardiac related conditions such as cardiac arrhythmias, ventricular tachycardia and ventricular fibrillation are expected to witness substantial growth over the forecast period. Increasing incidences of cardiovascular diseases and rising geriatric population base are some key factors expected to drive market growth by widening the patient base. Moreover, improving healthcare infrastructure and growing focus of key market players on emerging economies is also expected to fuel the growth of this market. Defibrillators are most commonly used to deliver therapeutic doses of electrical energy to the heart in case of a cardiac arrhythmia. Rising mortality rates associated with sudden cardiac arrest (SCA) has led to a consequential rise in demand for defibrillators.

Further key findings from the study suggest:

Implantable cardioverter defibrillator (ICD) is the most lucrative product segment. The global market for ICD is expected to grow at a rate of over 6.0% over the forecast period owing to their ability to avoid sudden cardiac arrest (SCA).
The product is also expected to remain as the most revenue generating segment of the market throughout the forecast period. The rise in demand for single and dual chamber ICDs are some factors expected to drive segment growth over the next six years.
North America accounted for more than 35.0% of the defibrillator market in 2013. High adoption rates of technologically advanced products and the presence of a sophisticated healthcare infrastructure in the region are some key factors expected to drive regional market growth. Moreover, growing geriatric population base and the prevalence of disease inducing lifestyle habits are expected to widen the patient base, thereby, providing manufacturers with future growth opportunities.
Asia Pacific is identified as the most lucrative region of the market. Presence of high unmet needs in the emerging markets of China and India and growing patient awareness levels are some factors expected to drive market growth over the forecast period.
Key players of this market include St. Jude Medical Inc, Boston Scientific Corporation, Biotronik SE & Co. KG, Sorin Group, ZOLL Medical Corporation, HeartSine Technologies, Nihon Kohden Corporation, Defibtech LLC, GE Healthcare, Welch Allyn, Koninklijke Philips N.V., Cardiac Science Corporation and Physio Control Inc.
For the purpose of this study, Grand View Research has segmented the global defibrillator market on the basis of products and region:

Global Defibrillator Market Product Outlook (Market Revenue in USD Million, 2012 - 2020)
Implantable Cardioverter Defibrillator
o Single Chamber Implantable Cardioverter Defibrillator
o Dual Chamber Implantable Cardioverter Defibrillator
External Defibrillator
o Manual External Defibrillator
o Automated External Defibrillator
o Wearable Cardioverter Defibrillators
Global Defibrillator End-use Outlook (Revenue, USD Million, 2012 - 2020)
Hospital
Pre Hospital
Public Access Market
Alternate Care Market
Home Health Care
Defibrillator Market Regional Outlook (Market Revenue in USD Million, 2012 - 2020)
North America
o U.S.
o Rest of North America
Europe
o Germany
o UK
o Rest of Europe
Asia Pacific
o Japan
o China
o India
o Rest of Asia Pacific
Latin America
o Brazil
o Mexico
o Rest of Latin America
Middle East and Africa
o South Africa
o Rest of Middle East and Africa

 Table of Contents

Chapter 1. Executive Summary
               1.1. Defibrillator Market - Industry Summary and Critical Success Factors (CSFs)
Chapter 2. Defibrillator Industry Outlook
               2.1. Defibrillator Market Segmentation
               2.2. Defibrillator Market Size and Growth Prospects
               2.3. Defibrillator Market Dynamics
                   2.3.1. Market Driver Analysis
                   2.3.2. Market Restraint Analysis
               2.4. Key Opportunities Prioritized
               2.5. Industry Analysis - Porter's
               2.6. Defibrillators Market PESTEL Analysis, 2013
Chapter 3. Defibrillator Product Outlook
               3.1. Defibrillator Market Share By Product, 2013 & 2020
               3.2. Implantable Cardioverter Defibrillator (ICDs)
                   3.2.1. Implantable Cardioverter Defibrillator Market Estimates and Forecasts, 2012 - 2020 (USD Million)
                       3.2.1.1. Single Chamber Implantable Cardioverter Defibrillator (T-ICDs) Market Estimates and Forecasts,                             2012 - 2020 (USD Million)
                   3.2.1.2. Dual Chamber Implantable Cardioverter Defibrillator (S-ICDs) Market Estimates and Forecasts, 2012 -                    2020 (USD Million)
               3.3. External Defibrillator (ICDs)
                   3.3.1. External Defibrillator Market Estimates and Forecasts, 2012 - 2020 (USD Million)
                       3.3.1.1. Manual External Defibrillator Market Estimates and Forecasts, 2012 - 2020 (USD Million)
                       3.3.1.2. Automated External Defibrillator (AED) Market Estimates and Forecasts, 2012 - 2020 (USD Million)
                       3.3.1.3. Wearable Cardioverter Defibrillator (WCDs) Market Estimates and Forecasts, 2012 - 2020 (USD                             Million)
Chapter 4. Defibrillator End Use Outlook
               4.1. Defibrillator Market Share By End Use, 2013 & 2020
               4.2. Hospitals 
                   4.2.1. Hospitals Market Estimates and Forecasts, 2012 - 2020 (USD Million)
               4.3. Pre-hospitals
                   4.3.1. Pre-hospitals Market Estimates and Forecasts, 2012 - 2020 (USD Million)
               4.4. Public Access Markets
                   4.4.1. Public Access Market Estimates and Forecasts, 2012 - 2020 (USD Million)
               4.5. Alternate Care Markets
                   4.5.1. Alternate Care Market Estimates and Forecasts, 2012 - 2020 (USD Million)
               4.6. Home Healthcare
                   4.6.1. Home Healthcare Market Estimates and Forecasts, 2012 - 2020 (USD Million)
Chapter 5. Defibrillator Regional Outlook
               5.1. Defibrillator Market Share By Region, 2013 & 2020
               5.2. North America
                   5.2.1. North America Defibrillator Market Estimates and Forecasts, 2012 - 2020 (USD Million)
                   5.2.2. U.S. Market Estimates and Forecasts
                   5.2.3. Canada Market Estimates and Forecasts
               5.3. Europe
                   5.3.1. Europe Defibrillator Market Estimates and Forecasts, 2012 - 2020 (USD Million)
                   5.3.2. Germany Market Estimates and Forecasts
                   5.3.3. UK Market Estimates and Forecasts
               5.4. Asia Pacific
                   5.4.1. Asia Pacific Defibrillator Market Estimates and Forecasts, 2012 - 2020 (USD Million)
                   5.4.2. Japan Market Estimates and Forecasts
                   5.4.3. China Market Estimates and Forecasts
                   5.4.4. India Market Estimates and Forecasts
               5.5. Latin America
                   5.5.1. Latin America Defibrillator Market Estimates and Forecasts, 2012 - 2020 (USD Million)
               5.6. Middle East
                   5.6.1. Middle East Defibrillator Market Estimates and Forecasts, 2012 - 2020 (USD Million)
Chapter 6. Competitive Landscape 
               6.1. Medtronic Inc.
                   6.1.1. Company Overview
                   6.1.2. Financial Performance
                   6.1.3. Product Benchmarking
                   6.1.4. Strategic Initiatives
               6.2. St. Jude Medical Inc.
                   6.2.1. Company Overview
                   6.2.2. Financial Performance
                   6.2.3. Product Benchmarking
                   6.2.4. Strategic Initiatives
               6.3. Boston Scientific Corporation
                   6.3.1. Company Overview
                   6.3.2. Financial Performance
                   6.3.3. Product Benchmarking
                   6.3.4. Strategic Initiatives
               6.4. BIOTRONIC SE & Co. KG
                   6.4.1. Company Overview
                   6.4.2. Financial Performance
                   6.4.3. Product Benchmarking
                   6.4.4. Strategic Initiatives
               6.5. Sorin Group
                   6.5.1. Company Overview
                   6.5.2. Financial Performance
                   6.5.3. Product Benchmarking
                   6.5.4. Strategic Initiatives
               6.6. Koninklijke Philips N.V.
                   6.6.1. Company Overview
                   6.6.2. Financial Performance
                   6.6.3. Product Benchmarking
                   6.6.4. Strategic Initiatives
               6.7. ZOLL Medical Corporation
                   6.7.1. Company Overview
                   6.7.2. Financial Performance
                   6.7.3. Product Benchmarking
                   6.7.4. Strategic Initiatives
               6.8. Cardiac Science Corporation
                   6.8.1. Company Overview
                   6.8.2. Financial Performance
                   6.8.3. Product Benchmarking
                   6.8.4. Strategic Initiatives
               6.9. Physio-Control Inc.
                   6.9.1. Company Overview
                   6.9.2. Financial Performance
                   6.9.3. Product Benchmarking
                   6.9.4. Strategic Initiatives
               6.10. Nihon Kohden corporation
                   6.10.1. Company Overview
                   6.10.2. Financial Performance
                   6.10.3. Product Benchmarking
                   6.10.4. Strategic Initiatives
               6.11. HeartSine Technologies
                   6.11.1. Company Overview
                   6.11.2. Financial Performance
                   6.11.3. Product Benchmarking
                   6.11.4. Strategic Initiatives
               6.12. Defibtech LLC
                   6.12.1. Company Overview
                   6.12.2. Financial Performance
                   6.12.3. Product Benchmarking
                   6.12.4. Strategic Initiatives
               6.13. GE Healthcare
                   6.13.1. Company Overview
                   6.13.2. Financial Performance
                   6.13.3. Product Benchmarking
                   6.13.4. Strategic Initiatives
               6.14. Welch Allyn
                   6.14.1. Company Overview
                   6.14.2. Financial Performance
                   6.14.3. Product Benchmarking
                   6.14.4. Strategic Initiatives
               6.15. Philips Healthcare
                   6.15.1. Company Overview
                   6.15.2. Financial Performance
                   6.15.3. Product Benchmarking
                   6.15.4. Strategic Initiatives
               6.16. Metrax
                   6.16.1. Company Overview
                   6.16.2. Financial Performance
                   6.16.3. Product Benchmarking
                   6.16.4. Strategic Initiatives
               6.17. Progetti S.R.I
                   6.17.1. Company Overview
                   6.17.2. Financial Performance
                   6.17.3. Product Benchmarking
                   6.17.4. Strategic Initiatives
               6.18. Schiller AG
                   6.18.1. Company Overview
                   6.18.2. Financial Performance
                   6.18.3. Product Benchmarking
                   6.18.4. Strategic Initiatives
               6.19. Fukuda Denshi USA Inc.
                   6.19.1. Company Overview
                   6.19.2. Financial Performance
                   6.19.3. Product Benchmarking
                   6.19.4. Strategic Initiatives
               6.20. Access Cardio Systems
                   6.20.1. Company Overview
                   6.20.2. Financial Performance
                   6.20.3. Product Benchmarking
                   6.20.4. Strategic Initiatives


List of Tables
1. Defibrillator - Industry summary &Critical Success Factors (CSFs)
2. Defibrillator Market by Product, (USD million), 2012 - 2020
3. Defibrillator Market - Key market drivers analysis
4. Defibrillator Market - Key market restraints analysis
5. Implantable Cardioverter Defibrillator (ICD) Market, 2012 to 2020 (USD million)
6. Single Chamber Implantable Cardioverter Defibrillator (T-ICD) Market, 2012 to 2020 (USD million)
7. Dual Chamber Implantable Cardioverter Defibrillator (S-ICD) Market, 2012 to 2020 (USD million)
8. External Defibrillator Market, 2012 to 2020 (USD million)
9. Manual External Defibrillators Market, 2012 to 2020 (USD million)
10. Automated External Defibrillators (AED) Market, 2012 to 2020 (USD million)
11. Wearable cardioverter Defibrillators (WCDs) Market, 2012 to 2020 (USD million)
12. Hospital Market, 2012 to 2020 (USD million)
13. Pre Hospital market, 2012 to 2020 (USD million)
14. Public Access Market, 2012 to 2020 (USD million)
15. Alternate Care Market, 2012 to 2020 (USD million)
16. Home Healthcare Market, 2012 to 2020 (USD million)
17. Defibrillators Market Revenue By Manufacturers,(USD million),2012 - 2020
18. Global Defibrillators Market, By Region, 2012 to 2020 (USD million)
19. North America Defibrillators Demand, By Product, (USD million), 2012 - 2020
20. Europe Defibrillators Demand, By Product, (USD million), 2012 - 2020
21. Asia Pacific Defibrillators Demand, By Product, (USD million), 2012 - 2020
22. RoW Defibrillators Demand, By Product, (USD million), 2012 - 2020


List of Figures
1. Defibrillator Market Segmentation
2. Global Defibrillator Market Revenue, 2012 - 2020
3. Defibrillator Market Dynamics
4. Key Opportunities Prioritized
5. Industry Analysis - Porter's
6. Defibrillators PESTEL Analysis, 2012
7. Global Defibrillator Market , By Product, (USD million), 2012 - 2020
8. Global Defibrillator Market, By Region 2012 to 2020 (USD million)
9. Implantable Cardioverter Defibrillator (ICD) Market, By Region, (USD million), 2012 - 2020
10. Single Chamber Implantable Cardioverter Defibrillator (T-ICD) Market, By Region, (USD million), 2012 - 2020
11. Dual Chamber Implantable Cardioverter Defibrillator (S-ICD) Market, By Region, (USD million), 2012 - 2020
12. External Defibrillator Market, By Region 2012 to 2020 (USD million)
13. Manual External Defibrillators Market, By Region 2012 to 2020 (USD million)
14. Automated External Defibrillators (AED) Market, By Region 2012 to 2020 (USD million)
15. Wearable Cardioverter Defibrillators (WCDs) market by region 2012 to 2020 (USD million)
16. Hospital Market, by region 2012 to 2020 (USD million)
17. Pre Hospital Market, by Region 2012 to 2020 (USD million)
18. Public Access Market, by Region 2012 to 2020 (USD million)
19. Alternate Care Market, by Region 2012 to 2020 (USD million)
20. Home Health Care Market, by Region 2012 to 2020 (USD million)